Form 8-K - Current report:
SEC Accession No. 0001193125-25-004999
Filing Date
2025-01-13
Accepted
2025-01-13 08:00:17
Documents
46
Period of Report
2025-01-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d906757d8k.htm   iXBRL 8-K 25166
2 EX-99.1 d906757dex991.htm EX-99.1 43774
6 GRAPHIC g906757ex99_1s10g1.jpg GRAPHIC 89565
7 GRAPHIC g906757ex99_1s11g1.jpg GRAPHIC 76708
8 GRAPHIC g906757ex99_1s12g1.jpg GRAPHIC 62536
9 GRAPHIC g906757ex99_1s13g1.jpg GRAPHIC 67335
10 GRAPHIC g906757ex99_1s14g1.jpg GRAPHIC 67590
11 GRAPHIC g906757ex99_1s15g1.jpg GRAPHIC 95510
12 GRAPHIC g906757ex99_1s16g1.jpg GRAPHIC 133793
13 GRAPHIC g906757ex99_1s17g1.jpg GRAPHIC 116191
14 GRAPHIC g906757ex99_1s18g1.jpg GRAPHIC 89478
15 GRAPHIC g906757ex99_1s19g1.jpg GRAPHIC 95565
16 GRAPHIC g906757ex99_1s1g1.jpg GRAPHIC 30435
17 GRAPHIC g906757ex99_1s20g1.jpg GRAPHIC 134861
18 GRAPHIC g906757ex99_1s21g1.jpg GRAPHIC 71834
19 GRAPHIC g906757ex99_1s22g1.jpg GRAPHIC 102206
20 GRAPHIC g906757ex99_1s23g1.jpg GRAPHIC 99509
21 GRAPHIC g906757ex99_1s24g1.jpg GRAPHIC 129104
22 GRAPHIC g906757ex99_1s25g1.jpg GRAPHIC 83540
23 GRAPHIC g906757ex99_1s26g1.jpg GRAPHIC 35152
24 GRAPHIC g906757ex99_1s27g1.jpg GRAPHIC 89557
25 GRAPHIC g906757ex99_1s28g1.jpg GRAPHIC 113342
26 GRAPHIC g906757ex99_1s29g1.jpg GRAPHIC 87554
27 GRAPHIC g906757ex99_1s2g1.jpg GRAPHIC 188236
28 GRAPHIC g906757ex99_1s30g1.jpg GRAPHIC 93814
29 GRAPHIC g906757ex99_1s31g1.jpg GRAPHIC 76217
30 GRAPHIC g906757ex99_1s32g1.jpg GRAPHIC 67849
31 GRAPHIC g906757ex99_1s3g1.jpg GRAPHIC 99967
32 GRAPHIC g906757ex99_1s4g1.jpg GRAPHIC 83479
33 GRAPHIC g906757ex99_1s5g1.jpg GRAPHIC 91567
34 GRAPHIC g906757ex99_1s6g1.jpg GRAPHIC 100205
35 GRAPHIC g906757ex99_1s7g1.jpg GRAPHIC 78929
36 GRAPHIC g906757ex99_1s8g1.jpg GRAPHIC 92153
37 GRAPHIC g906757ex99_1s9g1.jpg GRAPHIC 96528
  Complete submission text file 0001193125-25-004999.txt   4261351

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nmra-20250113.xsd EX-101.SCH 2856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nmra-20250113_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nmra-20250113_pre.xml EX-101.PRE 11265
48 EXTRACTED XBRL INSTANCE DOCUMENT d906757d8k_htm.xml XML 3639
Mailing Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472 (857) 760-0900
Neumora Therapeutics, Inc. (Filer) CIK: 0001885522 (see all company filings)

EIN.: 844367680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41802 | Film No.: 25524861
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)